ArticleUrolithiasis2026
Association between calcium-Sensing receptor gene polymorphisms and urinary calcium stone formation in the Han Chinese population from a High-Altitude region (Kunming) in China.
Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This case-control study investigated the association between calcium-sensing receptor (CaSR) gene polymorphisms and calcium-containing kidney stone susceptibility in 100 patients and 100 matched healthy controls from the Kunming Han Chinese population. Genotyping of three CaSR loci (rs1042636, rs1801725, and rs1801726) was performed using SNaPshot technology. The rs1801725 GT genotype significantly increased stone formation risk (odds ratio = 1.50, 95% confidence interval: 1.10-2.00, P = 0.042) and was associated with elevated 24-hour urinary calcium excretion compared with controls (10.683 ± 2.535 vs. 7.436 ± 1.742 mmol/24 h, P = 0.002), suggesting impaired renal tubular calcium reabsorption as the underlying mechanism. No significant association was found for rs1042636, while rs1801726 exhibited complete monomorphism (100% CC genotype) across all samples. This study provides the first evidence that the CaSR rs1801725 GT genotype serves as an independent genetic risk marker for urinary calcium stones in the Kunming Han Chinese population. Future research should integrate additional calcium transport pathway genes to develop polygenic risk prediction models and elucidate gene-environment interactions in stone pathogenesis.
Indexed as
Identifiers
41484479What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.